Successful Triple Combination Immunosuppressive Therapy with Prednisolone, Cyclosporine, and Mycophenolate Mofetil to Treat Recurrent Giant Cell Myocarditis

被引:8
|
作者
Akita, Tomomi [1 ]
Mori, Shumpei [1 ]
Onishi, Akira [2 ]
Hara, Shigeo [3 ]
Yamada, Haruhi [1 ]
Nagasawa, Akira [1 ]
Imada, Hiroshi [1 ]
Shimoura, Hiroyuki [1 ]
Ooka, Junichi [1 ]
Tanaka, Hidekazu [1 ]
Hirata, Ken-ichi [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kobe, Hyogo, Japan
[3] Kobe City Med Ctr Gen Hosp, Dept Diagnost Pathol, Kobe, Hyogo, Japan
关键词
Cyclosporine; giant cell myocarditis; mycophenolate mofetil; prednisolone; recurrence; DIAGNOSIS;
D O I
10.2169/internalmedicine.2471-18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 59-year-old man with a history of giant cell myocarditis was admitted to our hospital with recurrent giant cell myocarditis triggered by a 1 mg/day taper in his prednisolone dose. During the initial episode, he had undergone rescue implantation of a temporary left ventricular assist device followed by the administration of dual immunosuppressive therapy with prednisolone and concomitant cyclosporine. Triple combination immunosuppressive therapy maintained with additional mycophenolate mofetil successfully controlled recurrent myocarditis, enabled a reduction in the prednisolone dose, and achieved the functional recovery of the left ventricle.
引用
收藏
页码:2035 / 2039
页数:5
相关论文
共 50 条
  • [41] DIAGNOSIS OF RENAL-ALLOGRAFT REJECTION BY ANALYSIS OF INFILTRATING CELL PROFILES - AN ASSESSMENT OF CYCLOSPORINE, AZATHIOPRINE PREDNISOLONE, AND TRIPLE THERAPY
    MCWHINNIE, DL
    AZEVEDO, LS
    CARTER, NP
    CRANSTON, D
    JONES, R
    WOOD, RFM
    MORRIS, PJ
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1633 - 1634
  • [42] Successful Induction Therapy with Prednisolone and Maintenance Therapy with Cyclosporine for Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Case Report
    Kikuchi, Natsumi
    Kishimoto, Kenji
    Nakamura, Sayaka
    Ichikawa, Takayuki
    Nakatani, Naoko
    Nino, Nanako
    Tamura, Akihiro
    Yamamoto, Nobuyuki
    Kozaki, Aiko
    Saito, Atsuro
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S99 - S99
  • [43] A case of giant cell myocarditis: Bridge to recovery by long-term mechanical circulatory support without immunosuppressive therapy
    Murashita, Toshifumi
    Sugiki, Takashi
    Tachibana, Tsuyoshi
    Kunihara, Takashi
    Sugiki, Hiroshi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (02): : 432 - 433
  • [44] Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone
    Carbonella, Angela
    Berardi, Giorgia
    Petricca, Luca
    Biscetti, Federico
    Alivernini, Stefano
    Bosello, Silvia Laura
    Fedele, Anna Laura
    Ferraccioli, Gianfranco
    Gremese, Elisa
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (03) : 672 - U20
  • [45] Outcomes in Systemic Sclerosis Patients Treated with Rituximab and Mycophenolate Mofetil Combination Therapy Compared to Autologous Hematological Stem Cell Transplantation
    Keret, Shiri
    Kaly, Lisa
    Shouval, Aniela
    Zuckerman, Tsila
    Henig, Israel
    Awisat, Abid
    Rosner, Itzhak
    Rozenbaum, Michel
    Boulman, Nina
    Molad, Yair
    Lazar, Ariela Dortort
    Slobodin, Gleb
    Rimar, Doron
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3396 - 3398
  • [46] Daclizumab versus no induction therapy, in combination with cyclosporine microemulsion, mycophenolate mofetil, and corticosteroids, is associated with decreased acute rejection in cardiac transplant recipients and no observed increase in mortality
    Kobashigawa, J
    David, K
    Morris, J
    Chu, A
    Steffen, B
    Gordon, R
    CIRCULATION, 2004, 110 (17) : 752 - 752
  • [47] EVALUATION OF THE EARLY IV AND PO PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) AFTER LIVER TRANSPLANTATION IN COMBINATION THERAPY WITH TACROLIMUS OR CYCLOSPORINE A - A PROSPECTIVE RANDOMIZED SINGLE CENTER TRIAL
    Pascher, A.
    Selke, F.
    Reutzel-Selke, A.
    Bauer, S.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 58 - 58
  • [48] The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial
    Choi, Ji-Young
    Kim, Dong Ki
    Kim, Yang-Wook
    Yoo, Tae-Hyun
    Lee, Jung Pyo
    Chung, Hyun Chul
    Cho, Kyu Hyang
    An, Won Suk
    Lee, Duk-Hyun
    Jung, Hee-Yeon
    Cho, Jang-Hee
    Kim, Chan-Duck
    Kim, Yong-Lim
    Park, Sun-Hee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (09)
  • [49] The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Danylesko, Ivetta
    Shouval, Roni
    Nagler, Arnon
    Shimoni, Avichai
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (03) : 259 - 268
  • [50] The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Danylesko, Ivetta
    Nagler, Arnon
    Shimoni, Avichai
    BLOOD, 2015, 126 (23)